AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,095,269 | +496.7% | 172,308 | +516.4% | 0.02% | +650.0% |
| Q2 2023 | $351,127 | -87.0% | 27,956 | -88.5% | 0.00% | -87.5% |
| Q1 2023 | $2,702,711 | +212.4% | 243,707 | +243.9% | 0.02% | +220.0% |
| Q4 2022 | $865,237 | -9.9% | 70,863 | -23.0% | 0.01% | 0.0% |
| Q3 2022 | $960,000 | +312.0% | 91,976 | +324.2% | 0.01% | +400.0% |
| Q2 2022 | $233,000 | +109.9% | 21,680 | +85.1% | 0.00% | 0.0% |
| Q1 2022 | $111,000 | -93.3% | 11,712 | -91.8% | 0.00% | -93.8% |
| Q4 2021 | $1,650,000 | -50.5% | 142,860 | -59.0% | 0.02% | -61.9% |
| Q3 2021 | $3,330,000 | +86.7% | 348,685 | +88.4% | 0.04% | +110.0% |
| Q2 2021 | $1,784,000 | -55.5% | 185,109 | -54.3% | 0.02% | -60.8% |
| Q1 2021 | $4,005,000 | +84.5% | 405,412 | +331.3% | 0.05% | +70.0% |
| Q4 2020 | $2,171,000 | +34.3% | 94,007 | -17.8% | 0.03% | +25.0% |
| Q3 2020 | $1,616,000 | +57.0% | 114,420 | +67.7% | 0.02% | +33.3% |
| Q2 2020 | $1,029,000 | +392.3% | 68,245 | +201.7% | 0.02% | +200.0% |
| Q1 2020 | $209,000 | -79.7% | 22,623 | -78.6% | 0.01% | -68.4% |
| Q4 2019 | $1,031,000 | -62.1% | 105,882 | -68.8% | 0.02% | -64.8% |
| Q3 2019 | $2,723,000 | +533.3% | 339,473 | +884.7% | 0.05% | +575.0% |
| Q2 2019 | $430,000 | -88.7% | 34,474 | -87.6% | 0.01% | -93.5% |
| Q1 2019 | $3,795,000 | +4417.9% | 279,051 | +3086.2% | 0.12% | +2975.0% |
| Q4 2018 | $84,000 | -42.9% | 8,758 | -28.2% | 0.00% | -50.0% |
| Q3 2018 | $147,000 | +122.7% | 12,190 | +187.7% | 0.01% | +166.7% |
| Q2 2018 | $66,000 | +83.3% | 4,237 | +69.5% | 0.00% | +50.0% |
| Q4 2017 | $36,000 | -84.4% | 2,500 | -83.7% | 0.00% | -84.6% |
| Q3 2017 | $231,000 | +402.2% | 15,300 | +139.6% | 0.01% | +333.3% |
| Q1 2017 | $46,000 | +4500.0% | 6,386 | +4461.4% | 0.00% | – |
| Q4 2016 | $1,000 | -98.9% | 140 | -98.8% | 0.00% | -100.0% |
| Q3 2016 | $88,000 | -3.3% | 11,935 | -28.0% | 0.01% | +20.0% |
| Q2 2016 | $91,000 | -69.8% | 16,587 | -46.5% | 0.01% | -72.2% |
| Q4 2015 | $301,000 | -60.3% | 31,008 | -42.8% | 0.02% | -52.6% |
| Q3 2015 | $758,000 | +802.4% | 54,169 | +604.7% | 0.04% | +850.0% |
| Q1 2015 | $84,000 | -50.6% | 7,687 | -73.1% | 0.00% | -60.0% |
| Q3 2014 | $170,000 | – | 28,622 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |